Richard William Scalzo, See Remarks at Dyne Therapeutics, Inc. (DYN), sold 2,376 shares at $12.02 ($29K) on 2023-12-14, disclosed to the SEC on 2023-12-14.
Scheduled sale ($29k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DYN | SELL | 2025-03-13 | $15K | — | Filing → |
| DYN | SELL | 2025-03-07 | $11K | — | Filing → |
| DYN | SELL | 2025-02-18 | $35K | — | Filing → |